An alternative hypothesis, based on the negative impact of resveratrol on osteoclastic activity(20) and the close association of declining plasma CNP products with CTX during correction of hyperthyroidism,(16) predicts that plasma NTproCNP declines during resveratrol supplementation as markers of bone formation increase. The gene discussed is CNP; the disease is hyperthyroidism.